Terry Smith Zoetis Inc. Transaction History

Fundsmith LLP

$19.7 Billion
Q3 2025

A detailed history of Terry Smith (Fundsmith LLP) transactions in Zoetis Inc. stock. As of the latest transaction made, Fundsmith LLP holds 3,615,131 shares of ZTS stock, worth $429 Million. This represents 2.69% of its overall portfolio holdings.

Number of Shares

3,615,131

Previous 2,884,831 25.32%

Holding current value

$429 Million

Previous $450 Million 17.58%

% of portfolio

2.69%

Previous 1.97%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$141.13 - $159.19 $103 Million - $116 Million	730,300 Added 25.32%	3,615,131 $529 Million
Q2 2025 Aug 14, 2025	BUY	$144.41 - $170.3 $48.9 Million - $57.6 Million	338,344 Added 13.29%	2,884,831 $450 Million
Q1 2025 May 15, 2025	BUY	$156.48 - $175.67 $363 Million - $407 Million	2,319,158 Added 1020.18%	2,546,487 $419 Million
Q4 2024 Feb 14, 2025	SELL	$162.24 - $194.42 $551,129 - $660,444	-3,397 Reduced 1.47%	227,329 $37 Million
Q3 2024 Nov 14, 2024	BUY	$172.58 - $196.48 $435,074 - $495,326	2,521 Added 1.1%	230,726 $45.1 Million

Q2 2024 Aug 14, 2024	SELL	$145.54 - $178.83 $87,324 - $107,298	-600 Reduced 0.26%	228,205 $39.6 Million
Q1 2024 May 15, 2024	BUY	$165.67 - $199.94 $454,101 - $548,035	2,741 Added 1.21%	228,805 $38.7 Million
Q4 2023 Feb 14, 2024	BUY	$151.44 - $200.09 $493,845 - $652,493	3,261 Added 1.46%	226,064 $44.6 Million
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $69,697 - $80,385	417 Added 0.19%	222,803 $38.8 Million
Q2 2023 Aug 14, 2023	SELL	$160.94 - $186.23 $470,427 - $544,350	-2,923 Reduced 1.3%	222,386 $38.3 Million
Q1 2023 May 15, 2023	BUY	$145.48 - $175.02 $196,834 - $236,802	1,353 Added 0.6%	225,309 $37.5 Million
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $101,108 - $121,409	771 Added 0.35%	223,956 $32.8 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $167,864 - $206,646	1,132 Added 0.51%	223,185 $33.1 Million
Q2 2022 Aug 15, 2022	BUY	$155.97 - $200.09 $253,451 - $325,146	1,625 Added 0.74%	222,053 $38.2 Million
Q1 2022 May 16, 2022	SELL	$181.39 - $234.03 $7.83 Million - $10.1 Million	-43,186 Reduced 16.38%	220,428 $41.6 Million
Q4 2021 Feb 14, 2022	BUY	$193.69 - $247.03 $4.48 Million - $5.71 Million	23,112 Added 9.61%	263,614 $64.3 Million
Q3 2021 Nov 12, 2021	BUY	$189.29 - $209.69 $3.78 Million - $4.18 Million	19,947 Added 9.04%	240,502 $46.7 Million
Q2 2021 Aug 13, 2021	BUY	$155.9 - $187.99 $1.3 Million - $1.57 Million	8,348 Added 3.93%	220,555 $41.1 Million
Q1 2021 May 14, 2021	BUY	$144.0 - $169.39 $13.1 Million - $15.4 Million	91,204 Added 75.37%	212,207 $33.4 Million
Q4 2020 Feb 12, 2021	BUY	$157.07 - $174.35 $19 Million - $21.1 Million	121,003 New	121,003 $20 Million

Others Institutions Holding ZTS

# of Institutions

2,085

Shares Held

424M

Call Options Held

1.82M

Put Options Held

1.94M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $55.6B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track Terry Smith's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fundsmith LLP, based on Form 13F filings with the SEC.

News

Stay updated on Fundsmith LLP and Terry Smith with notifications on news.

Account